Cure My Disease

Don't miss your cure!

 Log in / Sign up

Fatty liver may be a hidden driver of heart attacks in diabetes

NCT ID NCT07706010

Not yet recruiting Knowledge-focused Sponsor: The Affiliated Hospital of Hangzhou Normal University Source: ClinicalTrials.gov ↗

First seen Jul 15, 2026 · Last updated Jul 16, 2026 · Updated 1 time

Summary

This study follows 7,000 adults with type 2 diabetes and a common form of fatty liver disease (MASLD) to see how liver problems influence the risk of heart attacks, strokes, and heart failure. Researchers will track participants for five years, using advanced models to separate the liver's effect from other risk factors like high blood pressure or cholesterol. The goal is to build a heart-risk prediction tool tailored for Chinese patients with both conditions, helping doctors spot high-risk individuals earlier.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

What this could lead to
If successful, this could lead to a better way to predict heart attacks and strokes in people with both type 2 diabetes and fatty liver disease, helping doctors intervene earlier.
What could go wrong
This is an observational study, not a treatment trial, so it cannot prove cause and effect. The findings may not apply to non-Chinese populations.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for METABOLIC DYSFUNCTION-ASSOCIATED STEATOTIC LIVER DISEASE are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

metabolic dysfunction-associated steatotic liver disease type 2 diabetes mellitus

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

METABOLIC DYSFUNCTION-ASSOCIATED STEATOTIC LIVER DISEASE TYPE 2 DIABETES (T2DM)

Contacts and locations

Study contacts

  • Contact

    Phone: •••-•••-•••• Email: •••••@•••••

Locations

  • MingWei Wang

    Hanzhou, Zhejiang, 310000, China

    Contact Phone: •••-•••-•••• Email: •••••@•••••

More trials for these conditions

Other studies related to the condition(s) this trial covers.